“...empathy is anything but a frill: not only is it crucial to doctors’ humanity and patients’ dignity, it can be key to medical efficacy. The rate of severe diabetes complications in patients of doctors who rate high on a standard empathy scale…is a remarkable 40 percent lower than in patients with low-empathy doctors. ‘This is comparable...to the benefits seen with the most intensive medical therapy for diabetes.’”

– Meghan O’Rourke in “Doctors Tell All – and It’s Bad” article in The Atlantic, published on October 14, 2014.

 “We need funding for care today while we wait for a cure tomorrow … We need to be creative and innovative, but we still need some one-on-one support.”

– Dr. Lori Laffel (Joslin Diabetes Center, Boston, MA) at the EASD Conference in Vienna, Austria

 “People expect to see better A1Cs. But even if you have the same A1c, but fewer peaks and valleys, that has value.”

– Dr. Julio Rosenstock (Dallas Diabetes & Endocrine Center, Dallas, TX) at the EASD Conference in Vienna, Austria

“One of our major problems in clinical diabetes is that very critical studies, for which companies will not make a profit, are unlikely to get done. We need to encourage both government and industry to work together to really try and answer questions that are important for diabetes, but may not make someone rich.”

– Dr. Harold Lebovitz (State University of New York, Brooklyn) at the EASD Conference in Vienna, Austria

Never miss an update by signing up here to receive free updates on future diaTribe articles.